Migreen kliinilised uuringud osariigis Texas
13 uuringut haiguse Migreen jaoks otsivad osalejaid osariigis Texas.
Linnad osariigis Texas
- Austin8 uuringut
- Houston7 uuringut
- Dallas5 uuringut
- El Paso3 uuringut
- San Antonio3 uuringut
- Grand Prairie3 uuringut
Ametlik uuringutekst (inglise keeles)
Study of EVO756 in Adults With Migraine
- FutureSearch Trials of Neurology, Austin
- FutureSearch Trials of Dallas, Dallas
- SFF Medical Research Group LLC, Houston
- ja veel 1
VärbamineFaas 2
Vanused 18–64 · Kõik sood · Uuendatud 2. okt 2026 · NCT07616128Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Alina Clinical Trials, LLC., Dallas
- North Texas Center for Clinical Research, Frisco
- DM Clinical Research - Cy Fair, Houston
- ja veel 6
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 28. sept 2026 · NCT05156398Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Dell Children's Medical Center, Austin
- Child Neurology Consultants of Austin - Central Austin, Austin
- Houston Clinical Trials, LLC, Bellaire
- ja veel 4
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 24. sept 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Dell Children's Medical Center, Austin
- Houston Clinical Trials, LLC, Bellaire
- FutureSearch Trials of Dallas, LLC, Dallas
- ja veel 5
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 24. sept 2026 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- UT Health Austin at Dell Childrens Neurology Clinic /ID# 270577, Austin
- Earle Research /ID# 270424, Houston
- Clinpoint Trials /ID# 270261, Waxahachie
VärbamineFaas 3
Vanused 12–17 · Kõik sood · Uuendatud 22. sept 2026 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- Dell Children's Hospital-UT Health, Austin
Värbamine
Vanused 10–17 · Kõik sood · Uuendatud 21. sept 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- DHR Health Headache Center, McAllen
VärbamineFaas 4
Vanused 18–70 · Kõik sood · Uuendatud 16. sept 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- UT Health Austin at Dell Children's Neurology Clinic /ID# 244266, Austin
- Austin Regional Clinic - ARC Four Points /ID# 276301, Austin
- Velocity Clinical Research, Austin /ID# 230557, Austin
- ja veel 13
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 14. sept 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- FutureSearch Trials of Neurology, Austin
- Tekton Research, Austin
- APD Clinical Research, Cypress
- ja veel 7
VärbamineFaas 3
Vanused 18–75 · Kõik sood · Uuendatud 20. aug 2026 · NCT07645924A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Road Runner Research Ltd, San Antonio
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 12. juuni 2026 · NCT05164172A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- FutureSearch Trials, Austin
VärbamineFaas 2
Vanused 18–70 · Kõik sood · Uuendatud 19. mai 2026 · NCT06602479Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs?
- University Medical Center of El Paso, El Paso
VärbamineVarajane 1. faas
Vanused 18–85 · Kõik sood · Uuendatud 6. mai 2026 · NCT06016465Stimulation of External Carotid Artery Circulation
- University of Texas Medical Branch, Galveston
Värbamine
Vanused 18–100 · Kõik sood · Uuendatud 20. veebr 2026 · NCT07402954Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.